Full-Time

Head of Value and Access Vaccines

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Global healthcare provider of medicines and vaccines

Biotechnology
Healthcare

Senior, Expert

Bridgewater Township, NJ, USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Requirements
  • Experience in payer/brand marketing.
  • Experience in working with US payers.
  • Experience in buy & bill products (strongly preferred).
  • Strong leadership skills and demonstrated ability to lead cross functionally.
  • Demonstrated experience in launching new products.
  • Deep understanding of Commercial, Medicare Part D and Medicaid.
  • Prior experience engaging with CMS on payment related topics (strongly preferred).
  • Experience identifying trends and insights assimilating into market/channel strategy.
  • Understanding of key payer value drivers and ability to develop and implement payer value propositions.
  • Experience developing presentations utilizing HEOR drivers for payors and/or formulary committees of large health systems.
  • Working understanding of strategic pricing and commercial contracting strategy, process and rules.
  • Demonstrated ability to identify and develop business opportunities based upon the above.
  • Deep understanding of the cross functional interactions between Account Management and Field Sales to ensure successful implementation of pull through plan.
  • Strong financial acumen, analytic skills & critical thinking ability.
  • Understanding of the legal/regulatory environment and internal Sanofi legal/regulatory guidelines and processes.
  • Ability to communicate at the executive level.
  • B.A. or B.S. Degree; Advanced Degree preferred.
  • 10+ years of relevant experience in the pharmaceutical healthcare sector.
  • 5-7 years in payer space (account management; payer marketing; contracting, etc.)
Responsibilities
  • Lead the V&A team in its execution of payer strategies for in-line and pipeline products.
  • Lead the V&A team in the development of educational reimbursement materials for dissemination via the reimbursement teams.
  • Lead the market access launch planning for all vaccine products notably RSV older adult and Expec.
  • Lead engagement on Federal payment strategy including potential future IRA negotiations.
  • Plan and manage the Vaccine BU V&A brand budget.
  • Participate with the brand planning and provide input into brand strategy development for.
  • Lead development and ensure alignment of all pricing/contracting strategies with the pricing team, tactics and initiatives to maximize profitability goals and add value to the organization.
  • Partner with HEVA business partners to inform real world evidence generation and ensure health economic activities are in place to meet the needs of payers while demonstrating value across the vaccine franchises.
  • Develop and communicate robust market access strategies and plans, including clear articulation of the brands’ value story, and help to integrate them into the overall brand plan.
  • Identify gaps in current market access understanding and develop plans to gain direct payer insights through primary research, advisory boards, etc., and work with vendors to implement projects in a timely, impactful manner.
  • Develop strong value communication platform and messaging in order to support access targets and goals.
  • Lead pull through opportunities and execution of pull through strategy for all channels and geographies based upon formulary position and opportunity.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tolebrutinib's FDA Breakthrough Therapy designation boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval for young children expands Sanofi's pediatric market.
  • Sanofi's partnership with BrightInsight accelerates digital health solution development.

What critics are saying

  • Liver enzyme elevations in tolebrutinib patients may affect market acceptance.
  • Increased competition in rare diseases from biotech startups challenges Sanofi.
  • Regulatory delays could impact Dupixent's approval for chronic spontaneous urticaria.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?